(Q44627982)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572647%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572647%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572647%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Dan Donnelly

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572647%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

0 references

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572647%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572647%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572647%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

342-346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572647%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572647%20AND%20SRC:MED&resulttype=core&format=json

Glucagon-like peptide-1 7-36: a physiological incretin in man.

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

New drug targets for type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Characterization of glucagon-like peptide-1 receptor-binding determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

The arrangement of the transmembrane helices in the secretin receptor family of G-protein-coupled receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

A highly sensitive adenylate cyclase assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Three distinct epitopes on the extracellular face of the glucagon receptor determine specificity for the glucagon amino terminus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Glucagon and GLP-1 receptors: lessons from chimeric ligands and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Insulinotropic glucagonlike peptide-I(7-37)/(7-36)amide A new incretin hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

High potency antagonists of the pancreatic glucagon-like peptide-1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand-receptor interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901043-3

10.1016/S0014-5793(03)01043-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572647%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference